Rochon C, Tauveron I, Dejax C, Benoit P, Capitan P, Fabricio A, Berry C, Champredon C, Thieblot P, Grizard J
Unité de Nutrition et Métabolisme Protéique, INRA Centre de Clermont-Ferrand, 63122 Saint-Genès Champanelle, France.
Clin Sci (Lond). 2003 Jan;104(1):7-15.
We have examined insulin action on glucose metabolism in six hypothyroid patients before and after regular thyroid hormone treatment, and in six healthy volunteers before and after transient induction of moderate hyperthyroidism. Insulin was infused under euglycaemic and eukalaemic clamps. An appropriate amino acid infusion was used to blunt insulin-induced decreases in amino acid levels. Glucose kinetics were assessed using a primed continuous infusion of [6,6-(2)H(2)]glucose. The results showed that basal plasma insulin and glucose levels (i.e. before infusion) were similar in each case. Despite similar insulin infusion rates, the plateau value of insulin was lower after thyroid treatment in both hypothyroid patients and healthy volunteers. The rate of exogenous glucose needed to maintain plasma glucose at a steady-state level was increased by thyroid hormone in hypothyroid patients (P <0.05), but not in healthy volunteers. Thyroid treatment resulted in a significant increase in basal glucose disposal in both groups (P <0.05). Insulin, in conjunction with glucose and amino acids, significantly stimulated glucose disposal (P <0.05) under all conditions. The incremental increase in glucose disposal after infusion tended to be higher following thyroid hormone treatment, but this was not statistically significant. However, the ratio of the incremental increase in glucose disposal to the increase in plasma insulin was significantly improved after thyroid hormone treatment in hypothyroid patients (P <0.05). It was also increased in healthy volunteers, but not significantly. We conclude that thyroid hormones improve the ability of insulin to stimulate glucose disposal related to insulinaemia. This phenomenon may be highly sensitive, because it was only apparent at low thyroid hormone levels.
我们研究了甲状腺激素常规治疗前后6例甲状腺功能减退患者以及短暂诱导中度甲状腺功能亢进前后6名健康志愿者体内胰岛素对葡萄糖代谢的作用。在正常血糖和正常血钾钳夹条件下输注胰岛素。使用适当的氨基酸输注来抑制胰岛素诱导的氨基酸水平下降。使用[6,6-(2)H(2)]葡萄糖的首剂量连续输注来评估葡萄糖动力学。结果显示,每种情况下基础血浆胰岛素和葡萄糖水平(即输注前)相似。尽管胰岛素输注速率相似,但甲状腺治疗后甲状腺功能减退患者和健康志愿者的胰岛素平台值均较低。甲状腺激素使甲状腺功能减退患者维持血浆葡萄糖稳态水平所需的外源性葡萄糖速率增加(P<0.05),但健康志愿者中未出现这种情况。甲状腺治疗使两组的基础葡萄糖处置均显著增加(P<0.05)。在所有条件下,胰岛素与葡萄糖和氨基酸联合使用均能显著刺激葡萄糖处置(P<0.05)。甲状腺激素治疗后输注后葡萄糖处置的增量增加趋势更高,但无统计学意义。然而,甲状腺功能减退患者甲状腺激素治疗后葡萄糖处置增量增加与血浆胰岛素增加的比值显著改善(P<0.05)。健康志愿者中该比值也有所增加,但不显著。我们得出结论,甲状腺激素可提高胰岛素刺激与胰岛素血症相关的葡萄糖处置的能力。这种现象可能高度敏感,因为仅在低甲状腺激素水平时才明显。